Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.


BACKGROUND Several trials show that tumor markers at primary diagnosis of cancer have prognostic relevance and can predict dissemination of the disease. While MUC-1 markers are frequently used to monitor treatment efficacy in metastatic breast cancer, their role at primary diagnosis or during follow-up remains unclear. This translational research project… (More)


2 Figures and Tables

Slides referencing similar topics